+34 620 10 75 37info@nanbiosis.com
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) & Jesus Usón Minimally Invasive Surgery Center (JUMISC) 10 Feb A new study shows how a tumor metabolite can make aggressive glioma cells more sensitive to treatment, revealing new opportunities for therapy. Valencia, February 2026 — A recent study published in Biomedicines shows that D-2-hydroxyglutarate (2HG), a molecule produced by certain brain[...] 04 Feb NANBIOSIS takes part in a key S4i 2026 round table on science–industry collaboration, highlighting Spain’s science industry and technology transfer. Madrid, February 2026 — Last week, NANBIOSIS contributed to a high-level round table at Science for Industry (S4i) 2026, an event focused[...] 10 Feb A new study shows how a tumor metabolite can make aggressive glioma cells more sensitive to treatment, revealing new opportunities for therapy. Valencia, February 2026 — A recent study published in Biomedicines shows that D-2-hydroxyglutarate (2HG), a molecule produced by certain brain[...] 04 Feb NANBIOSIS takes part in a key S4i 2026 round table on science–industry collaboration, highlighting Spain’s science industry and technology transfer. Madrid, February 2026 — Last week, NANBIOSIS contributed to a high-level round table at Science for Industry (S4i) 2026, an event focused[...] 10 Feb A new study shows how a tumor metabolite can make aggressive glioma cells more sensitive to treatment, revealing new opportunities for therapy. Valencia, February 2026 — A recent study published in Biomedicines shows that D-2-hydroxyglutarate (2HG), a molecule produced by certain brain[...] 04 Feb NANBIOSIS takes part in a key S4i 2026 round table on science–industry collaboration, highlighting Spain’s science industry and technology transfer. Madrid, February 2026 — Last week, NANBIOSIS contributed to a high-level round table at Science for Industry (S4i) 2026, an event focused[...]Welcome to Nanbiosis
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Ipsa dicta hic cupiditate dolor, aspernatur, blanditiis aperiam omnis corporis voluptatibus aut nihil a quis. Accusamus, numquam, accusantium ipsum itaque quidem expedita. Lorem ipsum dolor sit amet, consectetur adipisicing elit.Welcome to Nanbiosis - Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Latest From the Blog
How a tumor metabolite changes Glioma behavior and improves treatment response
NANBIOSIS strengthens science–industry collaboration at Science for Industry (S4i) 2026 round table
How a tumor metabolite changes Glioma behavior and improves treatment response
NANBIOSIS strengthens science–industry collaboration at Science for Industry (S4i) 2026 round table
How a tumor metabolite changes Glioma behavior and improves treatment response
NANBIOSIS strengthens science–industry collaboration at Science for Industry (S4i) 2026 round table
Units of Nanbiosis
About Nanbiosis
Responsive Design
It has never been easier to setup your website. With intuitive page builder and clear instructions, your site will be live in no time.
HiDPi Ready
With retina images, Shard looks crisp and sharp across the whole specter of devices. Simply Gorgeous!
Drag’n’drop builder
Shard is written with best code practices to date. This makes it preform well on all modern browsers and devices of all sizes
